Journal
Haematologica
Publication Date
12-1-2023
Volume
108
Issue
12
First Page
3511
Last Page
3516
Document Type
Open Access Publication
DOI
10.3324/haematol.2023.283566
Rights and Permissions
Aldoss I, Tizro P, Bedi D, Mangan JK, Clark MC, Spencer D, Song JY, Cherian S, Pillai R, Kim Y, Mahajan N, Gendzekhadze K, James M, Jacobs K, Davidson-Moncada J, Forman SJ, Wang HY, Afkhami M. Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia. Haematologica. 2023 Dec 1;108(12):3511-3516. doi: 10.3324/haematol.2023.283566. ©2023 Ferrata Storti Foundation Published under a CC BY-NC license
Recommended Citation
Aldoss, Ibrahim; Spencer, David; and et al., "Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia." Haematologica. 108, 12. 3511 - 3516. (2023).
https://digitalcommons.wustl.edu/oa_4/3081
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
